Partneringdesk Deals and Alliances In Autoimmune & Inflammatory DiseasesInnovaro PharmalicensingJune 1, 2006 1048 Pages - SKU: PL1284781 |
| Partneringdesk deals and alliances in autoimmune & inflammatory diseases provides an in-depth view of over 1100 deals and alliances announced in autoimmune & inflammatory diseases between 2001 and 2006, in a clear and accessible PDF format.
Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in autoimmune & inflammatory diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in:
Report scope The report contains:
This report provides a series of charts with analyses detailing market trends in autoimmune & inflammatory diseases deal making over the period of 2001 to 2006. Methodology This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources. |
Additional Information
Who should buy the report
This report is essential reading for board and executive management, and individuals in:
- business development
- licensing/partnering
- deal making
- business strategy
- marketing and promotion
- distribution and manufacturing (including contract services).
Abbott Laboratories
AstraZeneca
Aventis
Beckman Coulter Inc
Boehringer Ingelheim GmbH
Calypte Biomedical Corp
Celltech
Corixa
Dyax Corp
Genentech Inc
Genzyme Corporation
GlaxoSmithKline
International AIDS Vaccine Initiative
Medarex
MedImmune
MedMira
Merck & Co Inc
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Novartis AG
Pfizer Inc
Roche
Schering-Plough Corporation
Serono SA
ViroLogic

